House Energy and Commerce Committee staffers are concerned that "Right to Try" laws enacted by five states and under consideration by others will dilute the pool of people entering clinical trials, and say the committee's 21st Century Cures initiative may offer alternative ways to quicken patient access to new therapies without sidestepping the FDA approval process.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment